(Q35327883)

7 August 2017

title

Distribution and quantification of irinotecan and its active metabolite SN-38 in colon cancer murine model systems using MALDI MSI. (English)

1 reference

matrix-assisted laser desorption/ionization

7 August 2017

main subject

0 references

1 reference

1 reference

1 reference

7

Klaus-Peter Janssen

1 reference

7 August 2017

Achim Buck

1

1 reference

7 August 2017

Susanne Halbritter

2

1 reference

7 August 2017

Christoph Späth

3

1 reference

7 August 2017

Annette Feuchtinger

4

1 reference

7 August 2017

Michaela Aichler

5

1 reference

7 August 2017

Horst Zitzelsberger

6

1 reference

7 August 2017

Axel Walch

8

1 reference

7 August 2017

language of work or name

English

0 references

publication date

14 October 2014

1 reference

Analytical and Bioanalytical Chemistry

7 August 2017

published in

1 reference

7 August 2017

volume

407

1 reference

7 August 2017

issue

8

1 reference

7 August 2017

page(s)

2107-2116

1 reference

https://scigraph.springernature.com/pub.10.1007/s00216-014-8237-2

7 August 2017

exact match

0 references

cites work

Cellular roles of dna topoisomerases: a molecular perspective

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

DNA topoisomerases: structure, function, and mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Mouse liver and kidney carboxylesterase (M-LK) rapidly hydrolyzes antitumor prodrug irinotecan and the N-terminal three quarter sequence determines substrate selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Identification and activities of human carboxylesterases for the activation of CPT-11, a clinically approved anticancer drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

In situ drug and metabolite analysis [corrected] in biological and clinical research by MALDI MS imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Recent developments in PET detector technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Compound and metabolite distribution measured by MALDI mass spectrometric imaging in whole-body tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Matrix-assisted laser desorption/ionization mass spectrometric imaging of complete rat sections using a triple quadrupole linear ion trap

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Quantitative tandem mass spectrometric imaging of endogenous acetyl-L-carnitine from piglet brain tissue using an internal standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Evaluation of an accurate mass approach for the simultaneous detection of drug and metabolite distributions via whole-body mass spectrometric imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Quantification of small molecule drugs in biological tissue sections by imaging mass spectrometry using surrogate tissue-based calibration standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Central nervous system disposition and metabolism of Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: an LC-MS and Matrix-assisted laser desorption/ionization imaging MS investigation into central nervous system toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

mMass 3: a cross-platform software environment for precise analysis of mass spectrometric data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

The significance of microscopic mass spectrometry with high resolution in the visualisation of drug distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Drug transport in brain via the cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Experience with irinotecan for the treatment of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Synthesis, metabolite analysis, and in vivo evaluation of [(11)C]irinotecan as a novel positron emission tomography (PET) probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Drug penetration in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Quantitative MALDI tandem mass spectrometric imaging of cocaine from brain tissue with a deuterated internal standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

Delivery methods of camptothecin and its hydrosoluble analogue irinotecan for treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-014-8237-2

10.1007/S00216-014-8237-2

21 January 2018

Identifiers

DOI

1 reference

7 August 2017

1 reference